Tambe, Mahesh
Karjalainen, Ella
Vähä-Koskela, Markus
Bulanova, Daria
Gjertsen, Bjørn T. http://orcid.org/0000-0001-9358-9704
Kontro, Mika
Porkka, Kimmo
Heckman, Caroline A.
Wennerberg, Krister http://orcid.org/0000-0002-1352-4220
Funding for this research was provided by:
Helsingin Yliopisto
Kreftforeningen
Academy of Finland (277293)
Novo Nordisk Fonden (NNF17CC0027852)
Syöpäsäätiö
Sigrid Juséliuksen Säätiö
Article History
Received: 19 February 2020
Revised: 26 June 2020
Accepted: 2 July 2020
First Online: 10 July 2020
Compliance with ethical standards
:
: KW has received research funding from Novartis unrelated to this study. CAH has received research funding from Celgene, Novartis, Oncopeptides, and Orion Pharma unrelated to this study. BTG has received honoraria from Pfizer, Astellas, Daiichi Sankyo, Seattle Genetics, and BerGenBio and owns shares in KinN Therapeutics AS and ACTII AS. MK has received research funding from AbbVie unrelated to this study.